Friday, 3 March 2017

Portfolio2- High-Beta of Tomorrow

Hello Investors,
It’s past 5 months when we have published our first model portfolio undervalue-gems and since then it has delivered stellar 32 % upside so far against Sensex’s 3.69% return.
Now today we bring you our second model folio. This folio we count for investor who has above the average risk profile. So without waiting lets go to our list of high-beta stocks.
Portfolio2
High-Beta
Suzlon EnergyMarksan                Pharma   South India BankManali Petrochemical
SectorRenewable        EnergyPharmacyBankPetrochemical
Current Price (23thFeb )18.0549.720.5534.85
M cap(cr)906920343704599
P/E42121.229.5112.36
Industries P/E2727.6824.0330.29
Divined Yield00.242.431.43
EPS0.430.412.162.82
Book Value1.2310.0230.5716.43
Our Folio allocation (%)30302020

As you notice here we have listed 4 stocks where two are priced high in valuation with PE above industries PE  where other two are at low PE.
Now Suzlon and Marksan Pharmacy are two stock we picked which are currently coming from negative to positive trends. We strongly believe that this two stocks are turnaround story. You can read our last article on Suzlon ‘Suzlon- Wind is Started Flowing’. On other had Marksan Pharm recently got UK regulatory approval from its GOA plant. Year ago due to non-compliance issue stock halved and hit 40 from 100.
For rest two stock South India Bank and Manali Petrochemical, we find that market has valued this stock very low and any positive even can bring them to eye of market. Also both stocks are consistent dividend player which added in its value.
So if you are ready with fund and want some phenomenal return on long side with ability to withstand higher risk then you can pick this folio in one go.
Here we are keeping investment horizon more than 2 year because diamonds took time to get in shape and then shine.
Be Smart. Invest Smartly